Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@StableBread

Fajasy on X

Quantum $QMCO ran to $34.50 on October 2, 2026, and has fallen 41.3% since, to $20.25/share. No $QMCO insider has bought or sold shares in the open market since my August 16 update, including Dialectic, the activist fund managed by director John Fichthorn. Dialectic received 14.1M shares in June when it settled its convertible notes, 35.8% of the 39.4M shares outstanding, which makes it $QMCO’s largest shareholder. Its lockup, which also covered $QMCO’s officers and directors, ended on August 23, 30 days after the PIPE shares were registered for resale. So Dialectic could’ve sold into the run to $34.50, and it hasn’t reported a sale. On October 1, $QMCO granted options to buy shares at $31.885, that day’s close, to three executives: → Hugues Meyrath (CEO): 500,000 options. → James Clancy (COO): 400,000 options plus 150,000 RSUs. → Anthony Craythorne (Chief Revenue Officer): 200,000 options. The options vest monthly over four years and only pay off above $31.885, 57.5% above $20.25. CFO William White, fired eight days later, got no grant. So the largest holder hasn’t sold, and management’s new options only pay off above $31.885. But no insider bought during the drop either.
@convequity

Convequity on X

Buying an inference provider could make a software company's AI growth look much stronger. I partly agree with Sridhar. Ali Ghodsi's strengths extend well beyond technology into marketing, dealmaking and fundraising. I see Databricks as a very aggressive commercial operator, and staying private gives it more flexibility over which financial metrics the public gets to scrutinize. Snowflake ($SNOW) has to defend its growth alongside margins, stock-based compensation and dilution every quarter. Databricks has more room to prioritize the growth number in its public messaging while making trade-offs elsewhere. I'd like to see their full financials side by side. Separate core platform growth from inference resale, identify how much comes from AI-native customers, and quantify any benefit from changes in billing. Then compare gross profit, cash flow and dilution on the same basis. Inference is especially interesting here. A provider can collect a large customer bill while paying much of it to model or compute suppliers. Where accounting rules allow that full bill to be recognized as revenue, the business can add a lot of AI revenue for relatively little gross profit. That could make inference companies attractive acquisition targets for software vendors under pressure to show AI growth. Baseten and Fireworks come to mind, along with RadixArk and Inferact, founded by the creators of SGLang and vLLM respectively. These businesses offer serving technology and customers. An acquisition could also immediately increase the buyer's reported AI revenue, with a much smaller contribution to earnings if the acquired business has thin margins. The revenue boost would be acquired growth, so organic growth needs to remain visible. I wouldn't be surprised to see Snowflake and other publicly traded companies explore this route. If investors reward the added AI revenue more than the underlying gross profit warrants, buyers have an incentive to pay very high prices for these businesses.

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks

eToro: Expanding Beyond Crypto

EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…

ETOR $1.9B
Max Arnoldi 5 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 4 clicks

Coupang: 3Q26 Business Recap

Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…

CPNG $27B
Speedwell Memos 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.